| Aruna Divakaran Poduval, MD | |
|
2204 S Dobson Rd Ste 103, Mesa, AZ 85202 | |
| (480) 757-6457 | |
| (480) 378-7090 |
| Full Name | Aruna Divakaran Poduval |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 2204 S Dobson Rd Ste 103, Mesa, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174773717 | NPI | - | NPPES |
| 961725 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 49420 (Arizona) | Primary |
| Entity Name | Sonoran Pediatric Endocrinology & Diabetes Institute, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841721461 PECOS PAC ID: 0941557532 Enrollment ID: O20180730000185 |
News Archive
Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected.
The UK could be at the forefront of using technologies that enable patients to be cared for in the comfort of their home if the government adopted more imaginative approaches to supporting the NHS and industry working in this field, according to a report released today by researchers from Imperial College Business School.
The evidence shows more clearly than ever that having health insurance is essential for people's health and well-being, and safety-net services are not enough to prevent avoidable illness, worse health outcomes, and premature death, says a new report from the Institute of Medicine.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aruna Divakaran Poduval, MD 2204 S Dobson Rd Ste 103, Mesa, AZ 85202-6457 Ph: (480) 757-6457 | Aruna Divakaran Poduval, MD 2204 S Dobson Rd Ste 103, Mesa, AZ 85202 Ph: (480) 757-6457 |
News Archive
Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other tissues engineered from a patient's own biological material, are taking hold and working as expected.
The UK could be at the forefront of using technologies that enable patients to be cared for in the comfort of their home if the government adopted more imaginative approaches to supporting the NHS and industry working in this field, according to a report released today by researchers from Imperial College Business School.
The evidence shows more clearly than ever that having health insurance is essential for people's health and well-being, and safety-net services are not enough to prevent avoidable illness, worse health outcomes, and premature death, says a new report from the Institute of Medicine.
Niusule Biotech Corp. ("Niusule" or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced that the Company's popular Gummy Bear products will be distributed in Shanghai, the largest city in China.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
› Verified 6 days ago
Jyoti S. Lebonheur, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1840 S. Stapley Drive, Suite 101, Mesa, AZ 85204 Phone: 480-464-8500 | |
Dr. Eric Gabriel Gonzalez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 616 E Southern Ave, #103, Mesa, AZ 85204 Phone: 602-569-3999 Fax: 602-569-3887 | |
Pacita Tee Opulencia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 59 S Hibbert, Mesa, AZ 85210 Phone: 480-344-6226 Fax: 602-344-6201 | |
Dr. Daniel E Miga, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1432 S Dobson Rd Ste 512, Mesa, AZ 85202 Phone: 480-412-6336 Fax: 480-412-8013 | |
Naresh Reddivalla, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1432 S Dobson Rd Ste 107, Mesa, AZ 85202 Phone: 480-412-4100 | |
Dale W Guthrie, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4540 E Baseline Rd, Suite 108, Mesa, AZ 85206 Phone: 480-892-3880 Fax: 480-545-4551 | |
Dr. Leno Mammen Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1432 S Dobson Rd Ste 506, Mesa, AZ 85202 Phone: 480-412-6430 |